Show:
- Latest 6 months
- 2019
- 2018
- 2017
- 2016
Loading...
-
Orexo signs partnership agreement with GAIA to develop and commercialize a new digital therapy for the treatment of Opioid Use DisorderAug 20 2019
-
Orexo signs license and supply agreement with Mundipharma for Zubsolv® in Australia and New ZealandJul 10 2019
-
Orexo prepays part of the corporate bond loanJul 9 2019
-
Invitation to presentation of Orexo´s Q2 2019 Interim Report, on July 11Jul 5 2019
-
Orexo’s closest upcoming presentations at conferencesMay 17 2019
-
Invitation to presentation of Orexo´s Q1 2019 Interim Report, on May 2Apr 30 2019
-
Issues of shares following the vesting of 2016/2019 incentive planApr 26 2019
-
Report from Orexo AB’s annual general meetingApr 11 2019
